Yes, febuxostat and colchicine should be started together.
When initiating febuxostat for gout, you should strongly start colchicine prophylaxis concomitantly rather than starting febuxostat alone 1. This is a strong recommendation from the 2020 American College of Rheumatology guidelines based on moderate-quality evidence.
Why Start Them Together
The initiation of urate-lowering therapy like febuxostat causes mobilization of urate from tissue deposits due to changing serum uric acid levels, which paradoxically triggers gout flares 2. Starting colchicine prophylaxis at the same time prevents these flares during this vulnerable period.
Specific Dosing Strategy
For febuxostat:
- Start at ≤40 mg/day (not higher doses)
- Titrate upward gradually to reach target serum uric acid 1
For colchicine prophylaxis:
- 0.6 mg once or twice daily (maximum 1.2 mg/day for prophylaxis) 2
- Start immediately when febuxostat is initiated 2
Duration of Prophylaxis
Continue colchicine for 3-6 months minimum 1. The guidelines strongly recommend continuing prophylaxis for 3-6 months rather than less than 3 months, with ongoing evaluation and continued prophylaxis as needed if flares persist 1.
Research supports this approach: flare rates remain consistently low (3-5%) with 6 months of prophylaxis, whereas they spike sharply (up to 40%) when prophylaxis is stopped at 8 weeks 3. A Korean population study suggested at least 3 months may be more practical than 6 months for maximizing persistence 4, but the guideline recommendation of 3-6 months provides the safest approach.
Evidence of Effectiveness
Multiple studies confirm this strategy works:
- Colchicine prophylaxis reduces both frequency and severity of flares when starting febuxostat 5
- Network meta-analysis shows ULT plus colchicine reduces flare risk by 50% (RR 0.50) compared to ULT alone 6
- The combination is safe—no increased hepatotoxicity when febuxostat and colchicine are used together 7
Critical Safety Considerations
Do NOT use colchicine with febuxostat if:
- Patient has renal or hepatic impairment AND is taking strong CYP3A4 or P-gp inhibitors (protease inhibitors, clarithromycin, ketoconazole, etc.) 2
- This combination can cause fatal colchicine toxicity 2
Dose adjustments needed for:
- Renal impairment (reduce colchicine dose)
- Hepatic impairment (reduce colchicine dose)
- Drug interactions with CYP3A4/P-gp inhibitors (see FDA label for specific adjustments) 2
Common Pitfall to Avoid
The most common mistake is stopping colchicine too early (before 3 months) or not starting it at all when initiating febuxostat. This leads to preventable gout flares that cause patient suffering, reduce medication adherence, and undermine the entire urate-lowering strategy 1, 3.